Trial Profile
Influence of Recipient Cytochrome P450 3A5 Polymorphism on the Metabolism of Prolonged Release Tacrolimus Administered de Novo After Renal Transplantation
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Pharmacokinetics
- Acronyms CYRANO
- 12 Dec 2014 New trial record